Sort
15,273 grants matching “antimicrobial resistance”
Using an in vivo multi-lifetime model to test mechanisms of aging
$636,687David Masopust · University Of Minnesota · R01 · FY2025 · AG
Microbial Ecology-Guided Discovery of Antibacterial Drugs
$636,497Eric W Schmidt · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Defining the targets of broad intervention antimalarial agents
$636,473Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2016 · AI
NeoChip for specific and rapid identification of congenital CMV and neonatal HSV infections on minimal sample volume
$636,457Shelley M Lawrence · University Of California, San Diego · R01 · FY2021 · HD
Precision targeting of T cell cytotoxicity with PET
$635,683Michael John Evans · University Of California, San Francisco · R01 · FY2023 · CA
Development of novel anti-biofilm compounds for treating chronic wounds
$635,323Daina Zeng · Agile Sciences, Inc. · R44 · FY2015 · AI
Salmonella-specific therapeutics
$635,257Brian M Ahmer · Ohio State University · R01 · FY2021 · AI
In vivo Core
$634,768David R Andes · University Of Wisconsin-Madison · U19 · FY2023 · AI
Improving Quality of Care for the Treatment of Childhood Pneumonia
$634,576Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2011 · HD
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
$634,403Gayani Tillekeratne · Duke University · R01 · FY2022 · AI
Inhalation Therapy Platform for Coronavirus Infection Treatment
$634,365Patrick S. Stayton · University Of Washington · R01 · FY2021 · AI
Syphilis immunology and biology to improve clinical management and vaccine design
$634,347Jeffrey David Klausner · University Of California Los Angeles · R01 · FY2019 · AI
Role of Host Protein Kinase C in Cryptosporidiosis
$634,274Chelsea S. Marie · University Of Virginia · R01 · FY2020 · AI
Containing Bioterroist and Emerging Infectious Diseases
$634,266Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2008 · GM
H. influenzae: Role of Sialic Acid in Virulence
$634,104Michael A. Apicella · University Of Iowa · R01 · FY2011 · AI
Novel biofilm polymicrobial infection-resistant implants for otologic application
$634,028Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2009 · DC
Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
$633,851Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Development of antibacterial agents and materials
$633,833Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
H. influenzae: Role of Sialic Acid in Virulence
$633,704Michael A. Apicella · University Of Iowa · R01 · FY2012 · AI
H. influenzae: Role of Sialic Acid in Virulence
$633,704Michael A. Apicella · University Of Iowa · R01 · FY2014 · AI
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES
$633,396Clarence Buddy Creech · Vanderbilt University · N01 · FY2018 · AI
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$633,171John J Mekalanos · Harvard Medical School · R01 · FY2009 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$633,062Patrick S. Stayton · University Of Washington · R01 · FY2022 · AI
Risk factors for drug resistant pneumococcal bacteremia
$633,050Joshua P Metlay · University Of Pennsylvania · R01 · FY2007 · AI
Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by Dentists
$632,160Muhammad Walji · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DE